Insulin, Pharmacy Benefit Managers
Feds Sue Three Biggest Pharmacy Benefit Managers Over Insulin Costs
The US Federal Trade Commission said that CVS Health's Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum illegally steered patients to higher-priced insulins.
Pharmacy benefit managers respond to FTC's lawsuit over insulin drug prices
CNBC's Eamon Javers joins 'The Exchange' to report the latest on the FTC's lawsuit against drug middlemen for allegedly inflating insulin prices.
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have engaged in anticompetitive practices that spur price increases, the Federal Trade Commission alleged in a lawsuit filed Friday.
Federal regulators sue three pharmacy benefit managers over high insulin prices
The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
FTC sues major pharmacy benefit managers over insulin prices
The agency brought action against Caremark, Express Scripts and Optum Rx on Friday, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the list price of life-saving insulin drugs.
Express Scripts sues FTC over a ‘biased’ report about pharmacy benefit managers
Express Scripts, one of the largest pharmacy benefit managers in the U.S., filed a lawsuit demanding that a recent FTC report on industry middlemen be vacated.
FTC sues top three pharmacy middlemen over insulin prices
The Federal Trade Commission on Friday filed a lawsuit over insulin prices against the three largest pharmaceutical middlemen that negotiate prescription drug prices, arguing that the companies artificially inflate the costs of the lifesaving diabetes drug for patients.
Explainer: Why are US pharmacy benefit managers under fire?
The U.S. Federal Trade Commission said on Friday it was suing the country's three largest pharmacy benefit managers, accusing them of abusing their power and rigging the pharmaceutical supply chain to artificially inflate the cost of insulin.
FTC lawsuit claims drug middlemen are manipulating insulin market
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
Healthcare Finance News9m
FTC lawsuit claims rebate practices inflate insulin prices
Caremark, Express Scripts, Optum and their GPOs created a rebate system that boosted PBM profits, FTC alleges.
UnitedHealth, CVS Caremark, Express Scripts sued by FTC over skyrocketing insulin prices
The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
Express Scripts sues FTC over report blasting pharmacy middlemen
Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and ...